Psych-STRATA project was proud to be represented at the European Psychiatric Association (EPA) Congress 2025, held in Madrid earlier this month.
Dr. Chiara Fabbri, one of the project’s leading researchers, was present at the event and welcomed attendees at the GAMIAN-Europe booth (14A). Visitors had the chance to learn more about her work on advancing personalised approaches to mental health care, particularly in the area of treatment resistance in schizophrenia, bipolar disorder, and major depression.
Dr. Fabbri’s research focuses on integrating biological data to improve treatment outcomes for individuals who do not respond to standard therapies—one of the key aims of the Psych-STRATA project.
Psych-STRATA continues to contribute to the development of data-driven, personalised mental health care across Europe.
